|
1
|
Kloudova A, Guengerich FP and Soucek P:
The role of oxysterols in human cancer. Trends Endocrinol Metab.
28:485–496. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nelson ER, Chang CY and McDonnell DP:
Cholesterol and breast cancer pathophysiology. Trends Endocrinol
Metab. 25:649–655. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang KA, Chae S, Lee KH, Park MT, Lee SJ,
Lee YS and Hyun JW: Cytotoxic effect of 7beta-hydroxycholesterol on
human NCI-H460 lung cancer cells. Biol Pharm Bull. 28:1377–1380.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagano K, Imai S, Zhao X, Yamashita T,
Yoshioka Y, Abe Y, Mukai Y, Kamada H, Nakagawa S, Tsutsumi Y, et
al: Identification and evaluation of metastasis-related proteins,
oxysterol binding protein-like 5 and calumenin, in lung tumors. Int
J Oncol. 47:195–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kitayama J, Hatano K, Kaisaki S, Suzuki H,
Fujii S and Nagawa H: Hyperlipidaemia is positively correlated with
lymph node metastasis in men with early gastric cancer. Br J Surg.
91:191–198. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo E, Chen L, Xie Q, Chen J, Tang Z and
Wu Y: Serum HDL-C as a potential biomarker for nodal stages in
gastric cancer. Ann Surg Oncol. 14:2528–2534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen G, Feng W, Zhang S, Bian K, Yang Y,
Fang C, Chen M, Yang J and Zou X: Metformin inhibits gastric cancer
via the inhibition of HIF1α/PKM2 signaling. Am J Cancer Res.
5:1423–1434. 2015.
|
|
11
|
Valaee S, Yaghoobi MM and Shamsara M:
Metformin inhibits gastric cancer cells metastatic traits through
suppression of epithelial-mesenchymal transition in a
glucose-independent manner. PLoS One. 12:e01744862017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Singh PP and Singh S: Statins are
associated with reduced risk of gastric cancer: A systematic review
and meta-analysis. Ann Oncol. 24:1721–1730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Russell DW: The enzymes, regulation, and
genetics of bile acid synthesis. Annu Rev Biochem. 72:137–174.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johnson KA, Morrow CJ, Knight GD and
Scallen TJ: In vivo formation of 25-hydroxycholesterol from
endogenous cholesterol after a single meal, dietary cholesterol
challenge. J Lipid Res. 35:2241–2253. 1994.PubMed/NCBI
|
|
15
|
Hodis HN, Chauhan A, Hashimoto S, Crawford
DW and Sevanian A: Probucol reduces plasma and aortic wall
oxysterol levels in cholesterol fed rabbits independently of its
plasma cholesterol lowering effect. Atherosclerosis. 96:125–134.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lappano R, Recchia AG, De Francesco EM,
Angelone T, Cerra MC, Picard D and Maggiolini M: The cholesterol
metabolite 25-hydroxycholesterol activates estrogen receptor
α-mediated signaling in cancer cells and in cardiomyocytes. PLoS
One. 6:e166312011. View Article : Google Scholar
|
|
17
|
Simigdala N, Gao Q, Pancholi S,
Roberg-Larsen H, Zvelebil M, Ribas R, Folkerd E, Thompson A, Bhamra
A, Dowsett M, et al: Cholesterol biosynthesis pathway as a novel
mechanism of resistance to estrogen deprivation in estrogen
receptor-positive breast cancer. Breast Cancer Res. 18:582016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen L, Zhang L, Xian G, Lv Y, Lin Y and
Wang Y: 25-Hydroxycholesterol promotes migration and invasion of
lung adenocarcinoma cells. Biochem Biophys Res Commun. 484:857–863.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burkard I, von Eckardstein A, Waeber G,
Vollenweider P and Rentsch KM: Lipoprotein distribution and
biological variation of 24S- and 27-hydroxycholesterol in healthy
volunteers. Atherosclerosis. 194:71–78. 2007. View Article : Google Scholar
|
|
20
|
Yang P, Zhou Y, Chen B, Wan HW, Jia GQ,
Bai HL and Wu XT: Overweight, obesity and gastric cancer risk:
Results from a meta-analysis of cohort studies. Eur J Cancer.
45:2867–2873. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Gilkes DM, Semenza GL and Wirtz D: Hypoxia
and the extracellular matrix: Drivers of tumour metastasis. Nat Rev
Cancer. 14:430–439. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Høye AM and Erler JT: Structural ECM
components in the premetastatic and metastatic niche. Am J Physiol
Cell Physiol. 310:C955–C967. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yadav L, Puri N, Rastogi V, Satpute P,
Ahmad R and Kaur G: Matrix metalloproteinases and cancer - roles in
threat and therapy. Asian Pac J Cancer Prev. 15:1085–1091. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murray GI, Duncan ME, Arbuckle E, Melvin
WT and Fothergill JE: Matrix metalloproteinases and their
inhibitors in gastric cancer. Gut. 43:791–797. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Elnemr A, Yonemura Y, Bandou E, Kinoshita
K, Kawamura T, Takahashi S, Tochiori S, Endou Y and Sasaki T:
Expression of collagenase-3 (matrix metalloproteinase-13) in human
gastric cancer. Gastric Cancer. 6:30–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang M and Huang CZ: Mitogen-activated
protein kinase signaling pathway and invasion and metastasis of
gastric cancer. World J Gastroenterol. 21:11673–11679. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kanda N, Seno H, Konda Y, Marusawa H,
Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y,
et al: STAT3 is constitutively activated and supports cell survival
in association with survivin expression in gastric cancer cells.
Oncogene. 23:4921–4929. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang MD, Lai KC, Lai TY, Hsu SC, Kuo CL,
Yu CS, Lin ML, Yang JS, Kuo HM, Wu SH, et al: Phenethyl
isothiocyanate inhibits migration and invasion of human gastric
cancer AGS cells through suppressing MAPK and NF-kappaB signal
pathways. Anticancer Res. 30:2135–2143. 2010.PubMed/NCBI
|
|
30
|
Yakata Y, Nakayama T, Yoshizaki A, Kusaba
T, Inoue K and Sekine I: Expression of p-STAT3 in human gastric
carcinoma: Significant correlation in tumour invasion and
prognosis. Int J Oncol. 30:437–442. 2007.PubMed/NCBI
|
|
31
|
Duan H, Qu L and Shou C: Activation of
EGFR-PI3K-AKT signaling is required for Mycoplasma
hyorhinis-promoted gastric cancer cell migration. Cancer Cell Int.
14:1352014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Velázquez E, Santos A, Montes A, Blázquez
E and Ruiz-Albusac JM: 25-Hydroxycholesterol has a dual effect on
the proliferation of cultured rat astrocytes. Neuropharmacology.
51:229–237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Travert C, Carreau S and Le Goff D:
Induction of apoptosis by 25-hydroxycholesterol in adult rat Leydig
cells: Protective effect of 17beta-estradiol. Reprod Toxicol.
22:564–570. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choi YK, Kim YS, Choi IY, Kim SW and Kim
WK: 25-hydroxy-cholesterol induces mitochondria-dependent apoptosis
via activation of glycogen synthase kinase-3beta in PC12 cells.
Free Radic Res. 42:544–553. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang L and Sinensky MS:
25-Hydroxycholesterol activates a cytochrome c release-mediated
caspase cascade. Biochem Biophys Res Commun. 278:557–563. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
37
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gold ES, Diercks AH, Podolsky I,
Podyminogin RL, Askovich PS, Treuting PM and Aderem A:
25-Hydroxycholesterol acts as an amplifier of inflammatory
signaling. Proc Natl Acad Sci USA. 111:10666–10671. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Koarai A, Yanagisawa S, Sugiura H,
Ichikawa T, Kikuchi T, Furukawa K, Akamatsu K, Hirano T, Nakanishi
M, Matsunaga K, et al: 25-Hydroxycholesterol enhances cytokine
release and Toll-like receptor 3 response in airway epithelial
cells. Respir Res. 13:632012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha
TK, Byun DS, Chae KS, Lee BH, Chun HS, et al: NF-kappaB activates
transcription of the RNA-binding factor HuR, via PI3K-AKT
signaling, to promote gastric tumorigenesis. Gastroenterology.
135:2030–2042. 2042.e1–3. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Reboldi A, Dang EV, McDonald JG, Liang G,
Russell DW and Cyster JG: Inflammation. 25-Hydroxycholesterol
suppresses interleukin-1-driven inflammation downstream of type I
interferon. Science. 345:679–684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tricarico PM, Gratton R, Braga L, Celsi F
and Crovella S: 25-Hydroxycholesterol and inflammation in
Lovastatin-deregulated mevalonate pathway. Int J Biochem Cell Biol.
92:26–33. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
de Weille J, Fabre C and Bakalara N:
Oxysterols in cancer cell proliferation and death. Biochem
Pharmacol. 86:154–160. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hyun JW, Holl V, Weltin D, Dufour P, Luu B
and Bischoff P: Effects of combinations of 7beta-hydroxycholesterol
and anticancer drugs or ionizing radiation on the proliferation of
cultured tumor cells. Anticancer Res. 22:943–948. 2002.PubMed/NCBI
|
|
45
|
Erridge C, Webb DJ and Spickett CM:
25-Hydroxycholesterol, 7beta-hydroxycholesterol and
7-ketocholesterol upregulate interleukin-8 expression independently
of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages.
Free Radic Res. 41:260–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bauman DR, Bitmansour AD, McDonald JG,
Thompson BM, Liang G and Russell DW: 25-Hydroxycholesterol secreted
by macrophages in response to Toll-like receptor activation
suppresses immunoglobulin A production. Proc Natl Acad Sci USA.
106:16764–16769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang Y, Li Y, Li Y, Li R, Ma Y, Wang H
and Wang Y: Chloroquine inhibits MGC803 gastric cancer cell
migration via the Toll-like receptor 9/nuclear factor kappa B
signaling pathway. Mol Med Rep. 11:1366–1371. 2015. View Article : Google Scholar
|
|
48
|
Yue Y, Zhou T, Gao Y, Zhang Z, Li L, Liu
L, Shi W, Su L and Cheng B: High mobility group box 1/toll-like
receptor 4/myeloid differentiation factor 88 signaling promotes
progression of gastric cancer. Tumour Biol. Mar 28–2017.Epub ahead
of print. View Article : Google Scholar
|
|
49
|
Fernandez-Garcia B, Eiró N, González-Reyes
S, González L, Aguirre A, González LO, Del Casar JM, García-Muñiz
JL and Vizoso FJ: Clinical significance of toll-like receptor 3, 4,
and 9 in gastric cancer. J Immunother. 37:77–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
West AC, Tang K, Tye H, Yu L, Deng N,
Najdovska M, Lin SJ, Balic JJ, Okochi-Takada E, McGuirk P, et al:
Identification of a TLR2-regulated gene signature associated with
tumor cell growth in gastric cancer. Oncogene. 36:5134–5144. 2017.
View Article : Google Scholar : PubMed/NCBI
|
